Viewing nowCombinationDualow Tablet 60/2.5 mg
Fimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Korea Union Pharm Co., Ltd.

MFDS item code 202300123 · Approved 2023.01.06 · Insurance code 665508480
Improvement in blood pressure control for essential hypertension
Pimasartan potassium is a medication used for patients with essential hypertension who have difficulty controlling their blood pressure with monotherapy. This medication effectively lowers blood pressure and assists in its management. By appropriately managing blood pressure, it helps reduce the risk of cardiovascular complications. Therefore, pimasartan plays a crucial role in the treatment of hypertension and improves patients' health.
The recommended dosage of this medication is 1 tablet once daily, taken with water regardless of meals. It is advised to take it at the same time each day (e.g., morning). For patients whose blood pressure is not adequately controlled with pimasartan 30 mg monotherapy, 30/2.5 mg should be administered. For patients whose blood pressure is not adequately controlled with pimasartan 60 mg monotherapy, 60/2.5 mg should be administered.
The safety and efficacy in patients under 18 years of age have not been established.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so if pregnancy is confirmed, it should be discontinued immediately. Patients who are allergic to the active ingredients or dihydropyridine components should not take this medication. It is contraindicated in pregnant or breastfeeding women, patients undergoing renal dialysis, those with moderate to severe liver impairment, and patients with bile duct obstruction. Patients with diabetes or moderate to severe renal impairment using specific renin inhibitors should also not use this medication. Patients with lactose intolerance or specific genetic metabolic disorders should not take this medication. The use of this medication is prohibited in patients with severe aortic stenosis or in a state of shock. Caution is required when administering this medication to patients who are volume-depleted or hyponatremic, those with impaired kidney function, patients with renovascular hypertension, certain cardiac valve disorders, primary aldosteronism, severe hypotension, and the elderly. Patients allergic to the coloring agents contained in this medication should also exercise caution. Side effects such as dizziness, headache, facial swelling, urinary disturbances, insomnia, and flushing may occur; if abnormal symptoms appear, consult a doctor. There may be instances of excessive hypotension or hyperkalemia, so patients with heart failure or renal impairment should periodically check their potassium levels through blood tests. This medication may enhance blood pressure-lowering effects if taken with other antihypertensives or diuretics, so inform your doctor of any medications being taken. Pregnant or breastfeeding women should avoid taking this medication unless necessary; consult a physician for safe alternative medications. The safety and efficacy in children and adolescents under 18 years have not been established. Elderly patients may react more sensitively to this medication, necessitating caution. Patients with moderate or severe liver impairment should not take this medication. Overdosage may result in symptoms such as hypotension, palpitations, and bradycardia; in severe cases, emergency treatment may be necessary. This medication should be kept out of reach of children and should not be transferred to other containers, as this may degrade its quality.
Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blistering, skin peeling, pain in oral/ocular mucous membranes, shortness of breath or difficulty breathing, asthma attacks, respiratory problems accompanied by coughing and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urination
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it must be stored in a sealed container that blocks light. It is important to maintain a storage temperature between 1°C and 30°C. This helps preserve the medication's effectiveness and safety.
Yellow, rounded rectangular film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Korea Union Pharm Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 7.48mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 66.01mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Ajou Pharmaceuticals Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Kips Biopharma Co., Ltd.
CombinationFimasartan Potassium Trihydrate 33.005mg · S-Amlodipine Besylate 2.5 Hydrate 3.74mg
Tablet · Prescription medication · Combination
Bionex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.